CA2588168A1 - Formes sechees de preparations dosifiees d'acides biliaires solubilises aqueux, preparation et utilisations associees - Google Patents

Formes sechees de preparations dosifiees d'acides biliaires solubilises aqueux, preparation et utilisations associees Download PDF

Info

Publication number
CA2588168A1
CA2588168A1 CA002588168A CA2588168A CA2588168A1 CA 2588168 A1 CA2588168 A1 CA 2588168A1 CA 002588168 A CA002588168 A CA 002588168A CA 2588168 A CA2588168 A CA 2588168A CA 2588168 A1 CA2588168 A1 CA 2588168A1
Authority
CA
Canada
Prior art keywords
bile acid
acid
cndot
aqueous
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002588168A
Other languages
English (en)
Inventor
Seo Hong Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2588168A1 publication Critical patent/CA2588168A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
CA002588168A 2004-11-24 2004-11-24 Formes sechees de preparations dosifiees d'acides biliaires solubilises aqueux, preparation et utilisations associees Abandoned CA2588168A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/039507 WO2006057637A1 (fr) 2004-11-24 2004-11-24 Formes sechees de preparations dosifiees d'acides biliaires solubilises aqueux, preparation et utilisations associees

Publications (1)

Publication Number Publication Date
CA2588168A1 true CA2588168A1 (fr) 2006-06-01

Family

ID=34959579

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002588168A Abandoned CA2588168A1 (fr) 2004-11-24 2004-11-24 Formes sechees de preparations dosifiees d'acides biliaires solubilises aqueux, preparation et utilisations associees

Country Status (7)

Country Link
EP (1) EP1819318A1 (fr)
JP (1) JP2008521800A (fr)
CN (1) CN101065110A (fr)
AU (1) AU2004325203A1 (fr)
BR (1) BRPI0419213A (fr)
CA (1) CA2588168A1 (fr)
WO (1) WO2006057637A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
US9198885B2 (en) 2005-07-14 2015-12-01 Neothetics, Inc. Lipolytic methods for regional adiposity comprising salmeterol or formoterol
US9597531B2 (en) 2010-11-24 2017-03-21 Neothetics, Inc. Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
CN101035541B (zh) 2004-08-30 2012-05-30 柳署弘 溶解的udca在局灶缺血模型中的神经保护作用
EP1809330B1 (fr) 2004-10-15 2011-04-27 Seo Hong Yoo Methodes et compositions pour reduire la toxicite du cisplatine, carboplatine, et de l'oxaliplatine
WO2010062861A2 (fr) 2008-11-26 2010-06-03 Satiogen Pharmaceuticals, Inc. Inhibiteurs de recyclage de l'acide biliaire pour le traitement de l'obésité et du diabète
CN102316889B (zh) * 2008-11-26 2014-11-26 萨蒂奥根制药公司 组合物及使用方法
JP5420946B2 (ja) * 2009-03-23 2014-02-19 富士フイルム株式会社 胆汁酸を含むミノキシジル水性組成物
US20110152204A1 (en) * 2009-12-18 2011-06-23 Satiogen Pharmaceuticals, Inc. Treatment of Obesity or Diabetes with Bile Acid Sequestrants
WO2011150286A2 (fr) 2010-05-26 2011-12-01 Satiogen Pharmaceuticals,Inc. Inhibiteurs et satiogènes de recyclage d'acide biliaire pour traitement du diabète, de l'obésité et d'états inflammatoires gastro-intestinaux
CN101843823B (zh) * 2010-05-27 2014-04-09 宫兆荣 感抗注射液及其制备方法
US20130109671A1 (en) 2011-10-28 2013-05-02 Lumena Pharmaceuticals, Inc. Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
KR20180036580A (ko) * 2016-09-30 2018-04-09 주식회사 유스바이오팜 수가용화(水加溶化)된 우르소데옥시콜산을 함유하는 염증성 피부질환 또는 중증 소양증 예방 또는 치료용 조성물
KR102252450B1 (ko) * 2017-02-09 2021-05-14 주식회사 아미코젠파마 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물
CN108272824A (zh) * 2018-03-11 2018-07-13 张显英 一种胆汁提取工艺
KR102297982B1 (ko) * 2019-09-27 2021-09-02 건양대학교 산학협력단 담즙산을 이용한 장내 미생물 억제능 예측 키트를 이용한 억제능 예측방법
CN112138026A (zh) * 2020-10-28 2020-12-29 中南民族大学 一种熊胆粉在抗醉酒及预防急性酒精性脂肪肝药物中的应用
CN115671408A (zh) * 2022-10-29 2023-02-03 金傅(北京)医疗科技有限公司 一种能够避免肉芽组织增生的物质

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61171421A (ja) * 1985-08-23 1986-08-02 Yamanouchi Pharmaceut Co Ltd 安定なプロスタグランジンｅ類製剤の製造方法
JPS62153220A (ja) * 1985-12-27 1987-07-08 Tokyo Tanabe Co Ltd 胆汁酸内用水剤
JPH0747539B2 (ja) * 1986-10-22 1995-05-24 東京田辺製薬株式会社 胆汁酸固形製剤
JPS63243031A (ja) * 1987-03-28 1988-10-07 Tokyo Tanabe Co Ltd 胆汁酸の固形製剤
JPH0624991A (ja) * 1991-06-20 1994-02-01 Tokyo Tanabe Co Ltd ウルソデスオキシコール酸持続性製剤
US5578304A (en) * 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
IT1255968B (it) * 1992-11-27 1995-11-17 Composizioni farmaceutiche contenenti acido ursodesossicolico
LU88375A1 (fr) * 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Produit énergétique stimulant la puissance virile
KR100848344B1 (ko) * 2000-02-04 2008-07-25 유서홍 담즙산 함유 청정 수용액 제형의 제조

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9198885B2 (en) 2005-07-14 2015-12-01 Neothetics, Inc. Lipolytic methods for regional adiposity comprising salmeterol or formoterol
US9370498B2 (en) 2005-07-14 2016-06-21 Neothetics, Inc. Methods of using lipolytic formulations for regional adipose tissue treatment
US9452147B2 (en) 2005-07-14 2016-09-27 Neothetics, Inc. Lipolytic methods
US9707192B2 (en) 2005-07-14 2017-07-18 Neothetics, Inc. Lipolytic methods
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
US9452132B2 (en) 2009-05-27 2016-09-27 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
US9597531B2 (en) 2010-11-24 2017-03-21 Neothetics, Inc. Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging

Also Published As

Publication number Publication date
AU2004325203A1 (en) 2006-06-01
JP2008521800A (ja) 2008-06-26
WO2006057637A1 (fr) 2006-06-01
CN101065110A (zh) 2007-10-31
BRPI0419213A (pt) 2007-12-18
EP1819318A1 (fr) 2007-08-22

Similar Documents

Publication Publication Date Title
CA2406930C (fr) Preparation de formes posologiques a base de solutions aqueuse claires a partir d'acides biliaires
US20050158408A1 (en) Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7303768B2 (en) Preparation of aqueous clear solution dosage forms with bile acids
CA2588168A1 (fr) Formes sechees de preparations dosifiees d'acides biliaires solubilises aqueux, preparation et utilisations associees
IL151132A (en) Patridine compounds for the treatment of psoriasis
KR101358078B1 (ko) 근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물
US7932243B2 (en) Bile preparations for gastrointestinal disorders
US6251428B1 (en) Preparation of aqueous clear solution dosage forms with bile acids
US20020013292A1 (en) Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption
KR20080063401A (ko) 위장 장애를 위한 담즙 제제
US20070072828A1 (en) Bile preparations for colorectal disorders
JPH11506432A (ja) 結腸送達のためのビサコジル投与形態
US20100239661A1 (en) Pharmaceutical compositions of ursodiol
EP3419671A1 (fr) Préparations pharmaceutiques oromuqueuses à biodisponibilité élevée à base de cyclodextrine et de sucralose
PT94987A (pt) Processo para a preparacao de uma droga insoluvel na agua, anti-inflamatoria, nao esteroide, microencapsulada
WO2008033142A1 (fr) Préparations de bile pour affections rectocoliques
KR20070098821A (ko) 건조 형태의 수가용화 담즙산 투약 제형, 그의 제조방법 및용도
JP3122478B2 (ja) 下部消化管放出型経口製剤
US20040152663A1 (en) Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption
AU2006203315B2 (en) Preparation of aqueous clear solution dosage forms with bile acids
CN102697764A (zh) 一种含有异硫氰酸苯乙酯的肠溶固体制剂
RU2730488C1 (ru) Фармацевтическая композиция на основе глюкокортикостероида будесонида и фосфатидилхолина для сухой ингаляции

Legal Events

Date Code Title Description
FZDE Dead